SARS-CoV-2 genomics as a springboard for future disease mitigation in LMICs

This Genome Watch highlights how the SARS-CoV-2 pandemic laid the groundwork for continued use of real-time genomic epidemiology for public health responses in low-and-middle-income countries.

Saved in:
Bibliographic Details
Published in:Nature reviews. Microbiology 2022-01, Vol.20 (1), p.3-3
Main Authors: Belman, Sophie, Saha, Senjuti, Beale, Mathew A.
Format: Article
Language:English
Subjects:
631/208/325/2483
631/326/1762
631/326/596/4130
706/648/697
Africa - epidemiology
Bangladesh - epidemiology
Biomedical and Life Sciences
COVID-19 - diagnosis
COVID-19 - economics
COVID-19 - epidemiology
COVID-19 - transmission
Developing Countries - economics
Epidemiological Monitoring
Epidemiology
Genome Watch
Genome, Viral
Genomics
Genomics - economics
Genomics - instrumentation
Genomics - methods
Humans
Infectious Diseases
Life Sciences
Medical Microbiology
Microbiology
Nanopore Sequencing - economics
Nanopore Sequencing - instrumentation
Nanopore Sequencing - methods
Pandemics
Parasitology
Phylogeny
Public health
SARS-CoV-2 - classification
SARS-CoV-2 - genetics
SARS-CoV-2 - isolation & purification
SARS-CoV-2 - pathogenicity
Severe acute respiratory syndrome coronavirus 2
Viral diseases
Virology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:This Genome Watch highlights how the SARS-CoV-2 pandemic laid the groundwork for continued use of real-time genomic epidemiology for public health responses in low-and-middle-income countries.
ISSN:1740-1526
1740-1534
DOI:10.1038/s41579-021-00664-y